Personalizing Health Care—Is This the Right Time for Warfarin?
Open Access
- 26 March 2009
- journal article
- Published by Springer Nature in Journal of General Internal Medicine
- Vol. 24 (5) , 690-691
- https://doi.org/10.1007/s11606-009-0951-7
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Genetic Testing Before Anticoagulation? A Systematic Review of Pharmacogenetic Dosing of WarfarinJournal of General Internal Medicine, 2009
- Should We Test for CYP2C9 Before Initiating Anticoagulant Therapy in Patients with Atrial Fibrillation?Journal of General Internal Medicine, 2009
- Estimation of the Warfarin Dose with Clinical and Pharmacogenetic DataNew England Journal of Medicine, 2009
- Genome-wide Interrogation of Germline Genetic Variation Associated With Treatment Response in Childhood Acute Lymphoblastic LeukemiaJAMA, 2009
- Cytochrome P-450 Polymorphisms and Response to ClopidogrelNew England Journal of Medicine, 2009
- Pharmacology and Management of the Vitamin K AntagonistsChest, 2008
- Pharmacogenetic differences between warfarin, acenocoumarol and phenprocoumonThrombosis and Haemostasis, 2008
- Pharmacogenetics of warfarin: regulatory, scientific, and clinical issuesJournal of Thrombosis and Thrombolysis, 2007
- Effect ofVKORC1Haplotypes on Transcriptional Regulation and Warfarin DoseNew England Journal of Medicine, 2005
- The potential clinical and economic outcomes of pharmacogenetics-oriented management of warfarin therapy – a decision analysisThrombosis and Haemostasis, 2004